Stuart F. Schlossman

Stuart F. Schlossman's AcademicInfluence.com Rankings

Biology

#2325

World Rank

#3705

Historical Rank

Immunology

#77

World Rank

#83

Historical Rank

biology Degrees

Stuart F. Schlossman

Philosophy

#2133

World Rank

#3707

Historical Rank

Logic

#453

World Rank

#851

Historical Rank

philosophy Degrees

Download Badge

Biology
Philosophy

Why Is Stuart F. Schlossman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stuart F. Schlossman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. (1980) (1601)
The differentiation and function of human T lymphocytes (1980) (1458)
Monoclonal antibodies defining distinctive human T cell surface antigens. (1979) (1394)
An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein (1984) (1061)
Characterization of a human B lymphocyte-specific antigen. (1980) (1059)
Separation of functional subsets of human T cells by a monoclonal antibody. (1979) (1001)
A monoclonal antibody reactive with human peripheral blood monocytes. (1980) (831)
The isolation and characterization of the human suppressor inducer T cell subset. (1985) (829)
Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex (1983) (820)
A monoclonal antibody to human acute lymphoblastic leukaemia antigen (1980) (748)
Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. (1984) (722)
The isolation and characterization of the human helper inducer T cell subset. (1985) (700)
Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. (1980) (686)
A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. (1980) (671)
The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. (1988) (616)
Antigens on human monocytes identified by monoclonal antibodies. (1981) (608)
Expression of myeloid differentiation antigens on normal and malignant myeloid cells. (1981) (582)
Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression (1979) (582)
Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. (1982) (573)
Further characterization of the human inducer T cell subset defined by monoclonal antibody. (1979) (573)
B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. (1983) (520)
Direct association of adenosine deaminase with a T cell activation antigen, CD26. (1993) (511)
Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex (1982) (478)
Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. (1984) (468)
Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. (1980) (438)
The structure and function of CD26 in the T‐cell immune response (1998) (437)
Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. (1980) (435)
A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. (1979) (426)
A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. (1984) (426)
Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor (1983) (424)
A unique cell surface antigen identifying lymphoid malignancies of B cell origin. (1981) (421)
The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex. (1989) (404)
Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones (1983) (403)
Distribution of T cell subsets in human lymph nodes (1981) (399)
IEX-1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell Survival (1998) (398)
Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison (1980) (397)
A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells (1991) (380)
Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens (1978) (357)
The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies. (1980) (346)
Characterization of a human B cell-specific antigen (B2) distinct from B1. (1981) (326)
In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. (1985) (324)
Distribution of Ia-like molecules on the surface of normal and leukemic human cells. (1976) (323)
CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. (1997) (308)
Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex (1989) (305)
Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens (1987) (304)
Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). (1983) (300)
Hairy cell leukemia: a tumor of pre-plasma cells. (1985) (288)
Immunologic functions of isolated human lymphocyte subpopulations. I. Quantitative isolation of human T and B cells and response to mitogens. (1974) (275)
A QUANTITATIVE STUDY OF THE KINETICS OF BLOOD CLEARANCE OF P32-LABELLED ESCHERICHIA COLI AND STAPHYLOCOCCI BY THE RETICULO-ENDOTHELIAL SYSTEM (1959) (270)
Aberrations of suppressor T cells in human graft-versus-host disease. (1979) (270)
Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. (1985) (268)
Location of T cell and major histocompatibility complex antigens in the human thymus (1980) (259)
Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations. (1982) (259)
Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody. (1987) (254)
A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. (1996) (253)
Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man. (1981) (251)
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. (1985) (247)
Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. (1984) (242)
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT (1982) (238)
Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia. (1980) (238)
Stages of B cell differentiation in human lymphoid tissue (1981) (235)
The human T cell receptor: Appearance in ontogeny and biochemical relationship of α and β subunits on IL-2 dependent clones and T cell tumors (1983) (234)
Surface structures involved in target recognition by human cytotoxic T lymphocytes. (1982) (232)
VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectin (1990) (227)
Cloning and functional expression of the T cell activation antigen CD26. (1992) (222)
Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. (1980) (221)
Expression of cell surface markers after human B lymphocyte activation. (1981) (220)
STUDIES ON MEDIATOR PRODUCTION BY HIGHLY PURIFIED HUMAN T AND B LYMPHOCYTES (1974) (220)
Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. (1996) (220)
A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. (1990) (219)
Characterization of an antigen expressed by human natural killer cells. (1983) (217)
A subset of natural killer cells in peripheral blood displays a mature T cell phenotype (1986) (216)
A new member of the immunoglobulin superfamily that has a cytoplasmic region homologous to the leukocyte common antigen (1988) (216)
A monoclonal antibody blocking human T cell function (1980) (213)
Isolation and immunologic characterization of a human. B-lymphocyte- specific, cell surface antigen (1976) (211)
Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. (1991) (208)
The B cell surface molecule B1 is functionally linked with B cell activation and differentiation. (1985) (208)
The mouse mahogany locus encodes a transmembrane form of human attractin (1999) (207)
The characterization and function of human immunoregulatory T lymphocyte subsets. (1981) (206)
Abnormalities of immunoregulatory T cells in disorders of immune function. (1979) (205)
Phenotypic and functional heterogeneity of human cloned natural killer cell lines (1983) (205)
Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes. (1988) (201)
The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. (1993) (199)
CD3-negative natural killer cells express ε TCR as part of a novel molecular complex (1989) (198)
A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. (1987) (196)
Antigens on human plasma cells identified by monoclonal antibodies. (1983) (196)
Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma (1981) (196)
Differentiation patterns in the blastic phase of chronic myeloid leukemia. (1983) (196)
CD27-CD70 interactions regulate B-cell activation by T cells. (1995) (195)
Expression of Common Acute Lymphoblastic Leukemia Antigen (CALLA) by Lymphomas of B-Cell and T-Cell Lineage (1981) (194)
GENETIC CONTROL OF IMMUNE RESPONSES IN VITRO V. STIMULATION OF SUPPRESSOR T CELLS IN NONRESPONDER MICE BY THE TERPOLYMER L-GLUTAMIC ACID60-L-ALANINE30-L-TYROSINE10 (GAT) (1974) (191)
Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family (1990) (185)
Surface marker anaylsis of acute myeloblastic leukemia: identifi- cation of differentiation-associated phenotypes. (1983) (184)
Cyclic regulation of CD45 isoform expression in a long term human CD4+CD45RA+ T cell line. (1991) (182)
Identification and functional characterization of a TIA-1-related nucleolysin. (1992) (181)
1F7, a novel cell surface molecule, involved in helper function of CD4 cells. (1989) (180)
Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis. (1978) (179)
Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. (1982) (176)
Analysis of antigenic determinants on human monocytes and macrophages. (1982) (176)
CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO (2001) (170)
Specific purification of lymphocyte populations on a digestible immunoabsorbent. (1973) (165)
The delineation of antigen receptors on human T lymphocytes. (1983) (163)
Acquired immunodeficiency syndrome in a colony of macaque monkeys. (1983) (160)
Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations. (1985) (158)
Activation of human CD4 T lymphocytes. Interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor. (1991) (155)
The Human T Cell Receptor: Analysis with Cytotoxic T Cell Clones (1983) (155)
Direct evidence for loss of human suppressor cells during active autoimmune disease. (1978) (154)
Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. (1990) (153)
Identification of the receptor for antigen and major histocompatibility complex on human inducer T lymphocytes. (1983) (152)
Ligation of VLA-4 on T cells stimulates tyrosine phosphorylation of a 105-kD protein (1992) (152)
Specific release of proteoglycans from human natural killer cells during target lysis (1985) (148)
CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. (1997) (147)
Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes (1986) (145)
Comparative expression of T9, T10, and Ia antigens on activated human T cell subsets. (1981) (145)
Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells. (1990) (144)
Human lymphocyte subpopulations. (1977) (144)
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. (1998) (144)
CD molecules 2005: human cell differentiation molecules. (2005) (143)
Attractin (DPPT-L), a member of the CUB family of cell adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions. (1998) (140)
ANTI-B1 MONOCLONAL ANTIBODY AND COMPLEMENT TREATMENT IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED B-CELL NON-HODGKIN'S LYMPHOMA (1984) (139)
Detection, isolation, and functional characterization of two human T- cell subclasses bearing unique differentiation antigens (1977) (138)
Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis (1985) (137)
Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. (1994) (137)
Immunohistochemical staining of human brain with monoclonal antibodies that identify lymphocytes, monocytes, and the Ia antigen (1983) (136)
Cellular origin of interleukin 2 (IL 2) in man: evidence for stimulus-restricted IL 2 production by T4+ and T8+ T lymphocytes. (1982) (136)
Deficiency of suppressor T cells in the hyperimmunoglobulin E syndrome. (1981) (136)
The T11 (CD2) molecule is functionally linked to the T3/Ti T cell receptor in the majority of T cells. (1987) (134)
A biochemical function for attractin in agouti-induced pigmentation and obesity (2001) (134)
Immunologic functions of isolated human lymphocyte subpopulations. II. Antigen triggering of T and B cells in vitro. (1974) (133)
Abnormalities of T cell maturation and regulation in human beings with immunodeficiency disorders. (1981) (132)
Con A-inducible suppression of MLC: evidence for mediation by the TH2 + T cell subset in man. (1979) (131)
The cellular basis for lack of antibody response to hepatitis B vaccine in humans (1991) (131)
Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. (1990) (130)
Regulation of B cell immunoglobulin secretion by functional subsets of T lymphocytes in man (1980) (130)
Cross-linking of T3 (CD3) with T4 (CD4) enhances the proliferation of resting T lymphocytes. (1987) (128)
T-cell surface antigens in a patient with blast crisis of chronic myeloid leukemia (1983) (127)
CD27 is a signal-transducing molecule involved in CD45RA+ naive T cell costimulation. (1994) (126)
Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukocyte common antigens. (1988) (126)
A Novel Form of Dipeptidylpeptidase IV Found in Human Serum. (1995) (123)
Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. (1996) (122)
Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation. (2000) (122)
Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells. (1985) (122)
T cell requirements for generation of helper factor(s) in man: analysis of the subsets involved. (1980) (121)
Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7. (1997) (120)
Comparison of T3-associated 49- and 43-kilodalton cell surface molecules on individual human T-cell clones: evidence for peptide variability in T-cell receptor structures. (1983) (118)
Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation. (1997) (117)
Structural analysis of differentiation antigens Mo1 and Mo2 on human monocytes. (1982) (116)
Molecular Interactions, T‐Cell Subsets and a Role of the CD4/CD8:p56lck Complex in Human T‐Cell Activation (1989) (115)
Antibody directed at a surface structure inhibits cytolytic but not suppressor function of human T lymphocytes (1981) (113)
Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. (1991) (113)
A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells (1987) (112)
Isolation and characterization of naturally occurring subclasses of human peripheral blood T cells with regulatory functions. (1978) (112)
Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen (1987) (109)
Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody. (1985) (108)
Immunodeficiency associated with loss of T4+ inducer T-cell function. (1981) (108)
CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response. (1999) (107)
Autoantibody to an immunoregulatory inducer population in patients with juvenile rheumatoid arthritis. (1981) (105)
Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia. (1982) (104)
Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions. (1984) (103)
T lymphocyte surface antigens in primates (1983) (103)
The subdivision of the T4 (CD4) subset on the basis of the differential expression of L-C/T200 antigens (1987) (102)
Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice (2002) (102)
Expression of normal monocyte-macrophage differentiation antigens on HL60 promyelocytes undergoing differentiation induced by leukocyte-conditioned medium or phorbol diester. (1981) (101)
Human antigen‐specific memory T cells express the homing receptor (LAM‐1) necessary for lymphocyte recirculation (1990) (101)
Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients. (1980) (101)
Alpha and beta chains of SB and DR antigens are structurally distinct (1982) (100)
Generation of a cloned NK cell line derived from the "null cell" fraction of human peripheral blood. (1982) (97)
Biosynthesis and surface expression of T8 by peripheral blood T4+ cells in vitro. (1986) (96)
Surface marker analysis of acute myeloblastic leukemia: identification of differentiation-associated phenotypes. (1983) (95)
Siva-1 binds to and inhibits BCL-XL-mediated protection against UV radiation-induced apoptosis (2002) (95)
Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases. (1988) (94)
Cytotoxicity and apoptosis in human renal allografts: identification, distribution, and quantitation of cells with a cytotoxic granule protein GMP-17 (TIA-1) and cells with fragmented nuclear DNA. (1997) (94)
Structural and functional characterization of IL 2 receptors on activated human B cells. (1985) (93)
Structure of the gene encoding the human B lymphocyte differentiation antigen CD20 (B1). (1989) (92)
Direct demonstration of the human suppressor inducer subset by anti-T cell antibodies. (1983) (91)
Cross‐linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen‐activated protein kinase (1997) (90)
The role of the 2H4 molecule in the generation of suppressor function in Con A-activated T cells. (1986) (90)
Induction of proliferation of purified human myeloid progenitor cells: a rapid assay for granulocyte colony-stimulating factors. (1984) (90)
A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells. (1984) (90)
Immunologic functions of isolated human lymphocyte subpopulations. VI. Further characterization of the surface Ig negative, E rosette negative (null cell) subset. (1975) (89)
Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells. (1996) (89)
CD134L Engagement Enhances Human B Cell Ig Production: CD154/CD40, CD70/CD27, and CD134/CD134L Interactions Coordinately Regulate T Cell-Dependent B Cell Responses1 (2000) (89)
Peptide variability exists within alpha and beta subunits of the T cell receptor for antigen (1983) (89)
Complete exon-intron organization of the human leukocyte common antigen (CD45) gene. (1988) (88)
Serologic identification of the human secondary B cell antigens. Correlations between function, genetics, and structure (1982) (86)
Immunoregulatory T‐cells and lymphocytotoxic antibodies in active multiple sclerosis: Weekly analysis over a six‐month period (1983) (86)
Cloning of a complementary DNA encoding a new mouse B lymphocyte differentiation antigen, homologous to the human B1 (CD20) antigen, and localization of the gene to chromosome 19. (1988) (86)
T-cell-subset characterization of human T-CLL. (1979) (86)
Immunogenicity of a series of alpha,N-DNP-L-lysines. (1965) (85)
Subpopulations of the T4+ inducer T cell subset in man: evidence for an amplifier population preferentially expressing Ia antigen upon activation. (1981) (85)
Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody. (1983) (84)
1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. (1991) (84)
Clonotypic Surface Structure on Human T Lymphocytes: Functional and Biochemical Analysis of the Antigen Receptor Complex (1984) (84)
SPECIFIC FRACTIONATION OF A POPULATION OF ANTIDEXTRAN MOLECULES WITH COMBINING SITES OF VARIOUS SIZES (1962) (83)
Secreted and membrane attractin result from alternative splicing of the human ATRN gene. (2000) (83)
Biochemical identification of a direct physical interaction between the CD4: p56lck and Ti(TcR)/CD3 complexes (1991) (82)
Delineation of an immunoregulatory amplifier population recognizing autologous Ia molecules. Analysis with human T cell clones (1984) (81)
Comodulation of CD3 and CD4. Evidence for a specific association between CD4 and approximately 5% of the CD3:T cell receptor complexes on helper T lymphocytes. (1988) (81)
Phosphorylation of the B1 (CD20) molecule by normal and malignant human B lymphocytes. (1988) (80)
Purification and NH2-terminal amino acid sequencing of the beta subunit of a human T-cell antigen receptor. (1984) (79)
Functional Interaction of DFF35 and DFF45 with Caspase-activated DNA Fragmentation Nuclease DFF40* (1999) (79)
Ontogeny of human hematopoietic cells: analysis utilizing monoclonal antibodies. (1983) (79)
A cell surface receptor defined by a mAb mediates a unique type of cell death similar to oncosis. (1998) (78)
Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies. (1992) (77)
CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation. (1992) (76)
Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis. (1994) (76)
4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro (1987) (75)
Characteristics of anti-T-cell antibodies in systemic lupus erythematosus: evidence for selective reactivity with normal suppressor cells defined by monoclonal antibodies. (1980) (75)
Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients. (1993) (75)
Human cytotoxic T cell clones directed at autologous virus-transformed targets: further evidence for linkage of genetic restriction to T4 and T8 surface glycoproteins. (1983) (75)
Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells. (1975) (75)
Leukemia-associated antigens in ALL. (1979) (75)
Structural similarity between Fc receptors and T cell receptors. Expression of the gamma-subunit of Fc epsilon RI in human T cells, natural killer cells and thymocytes. (1991) (74)
Immunologic responses of progressive multiple sclerosis patients treated with an anti‐T‐cell monoclonal antibody, anti‐T12 (1986) (74)
A monoclonal antibody that blocks class II histocompatibility-related immune interactions. (1984) (73)
Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies. (1981) (73)
Molecular cloning of Porimin, a novel cell surface receptor mediating oncotic cell death (2001) (73)
Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth (1987) (73)
Subset derivation of T-cell acute lymphoblastic leukemia in man. (1979) (73)
Biochemical and genetic studies of pigment-type switching. (2000) (73)
A monoclonal antibody defining a lymphoma-associated antigen in man. (1980) (72)
Phosphorylation of CD4 and CD8 molecules following T cell triggering. (1987) (72)
B5, a new B cell-restricted activation antigen. (1985) (72)
Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells. (1985) (71)
IMMUNOCHEMICAL STUDIES ON THE SPECIFICITY OF CELLULAR HYPERSENSITIVITY (1968) (71)
Acquisition of immune competence by a subset of human cortical thymocytes expressing mature T cell antigens. (1982) (70)
A rapid method for separating functionally intact human T lymphocytes with monoclonal antibodies. (1981) (69)
THE COMPARTMENTALIZATION OF ANTIGEN-REACTIVE LYMPHOCYTES IN DESENSITIZED GUINEA PIGS (1971) (68)
Expression of a 26,000-dalton glycoprotein on activated human T cells. (1981) (67)
Use of surface markers to identify a subset of acute myelomonocytic leukemia cells with progenitor cell properties. (1983) (67)
CSF cells in multiple sclerosis (1983) (67)
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates. (1986) (67)
Evidence for specific association between class I major histocompatibility antigens and the CD8 molecules of human suppressor/cytotoxic cells (1988) (66)
Functional and phenotypic studies of Japanese adult T cell leukemia cells. (1985) (66)
Monoclonal antibody identifies a new Ia-like (p29,34) polymorphic system linked to the HLA-D/DR region (1981) (65)
Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes. (1983) (65)
Isolation of myeloid progenitor cells from peripheral blood of chronic (1982) (64)
IMMUNOCHEMICAL STUDIES ON THE ANTIGENIC DETERMINANTS REQUIRED TO ELICIT DELAYED AND IMMEDIATE HYPERSENSITIVITY REACTIONS (1966) (64)
2H1--a novel antigen involved in T lymphocyte triggering. (1988) (63)
Monocytes are required to prime peripheral blood T cells to undergo apoptosis. (1995) (63)
Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27. (1994) (63)
DRw antisera react with activated T cells. (1979) (63)
Human T lymphocyte subsets. Functional heterogeneity and surface recognition structures. (1984) (63)
Delineation of an effector population responsible for natural killing and antibody-dependent cellular cytotoxicity in man. (1981) (63)
Purification of common acute lymphoblastic leukemia antigen positive cells from normal human bone marrow. (1984) (62)
CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions. (1992) (61)
An enzyme-linked immunosorbent assay (ELISA) for the detection of monoclonal antibodies to cell surface antigens on viable cells. (1982) (61)
Alterations of T-cell subsets in primary biliary cirrhosis. (1982) (61)
Distribution and modulation of a human leukemia-associated antigen (CALLA). (1983) (60)
Communicative interactions between subpopulations of human T lymphocytes required for generation of suppressor effector function in a primary antibody response. (1982) (60)
B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients. (2001) (60)
Monoclonal antibodies reactive with the T cell receptor zeta chain: production and characterization using a new method. (1989) (59)
The 4F9 antigen is a member of the tetra spans transmembrane protein family and functions as an accessory molecule in T cell activation and adhesion. (1993) (59)
Ontogeny of human T and B lymphocytes during stressed and normal gestation: phenotypic analysis of umbilical cord lymphocytes from term and preterm infants. (1985) (58)
Comparison in T- and B-cell markers in patients with Sjögren's syndrome and systemic lupus erythematosus. (1982) (57)
Murine Siva-1 and Siva-2, alternate splice forms of the mouse Siva gene, both bind to CD27 but differentially transduce apoptosis (1999) (57)
Immunologic functions of isolated human lymphocyte subpopulations. III. Specific allogeneic lympholysis mediated by human T cells alone. (1975) (56)
Total lymphoid irradiation therapy in refractory rheumatoid arthritis. Fifteen- to forty-month followup. (1984) (54)
Attractin: a cub-family protease involved in T cell-monocyte/macrophage interactions. (2000) (54)
The gene that encodes the human CD20 (B1) differentiation antigen is located on chromosome 11 near the t(11;14)(q13;q32) translocation site. (1989) (54)
Inhibition of antibody-dependent cellular cytotoxicity and immunoglobulin synthesis by an antiserum prepared against a human B- cell Ia-like molecule (1976) (54)
Heterogeneity of T-cell lymphoblastic malignancies. (1980) (54)
Direct cellular communications between CD45R0 and CD45RA T cell subsets via CD27/CD70. (1995) (54)
The cellular basis for the induction of antigen‐specific T8 suppressor cells (1986) (54)
CD4+CD45RA+ and CD4+CD45RA- T cell subsets in man maintain distinct function and CD45RA expression persists on a subpopulation of CD45RA+ cells after activation with Con A. (1990) (53)
Mature bone marrow erythroid burst-forming units do not require T cells for induction of erythropoietin-dependent differentiation (1980) (53)
Suppressor cell regulation of immune response to tumors: abrogation by adult thymectomy. (1977) (52)
Immunologic functions of isolated human lymphocyte subpopulations. V. Isolation and functional analysis of a surface Ig negative, E rosette negative subset. (1975) (52)
Regulation of the alternative pathway of T cell activation by anti-T3 monoclonal antibody. (1986) (51)
FcR-mediated crosslinking of Ta1 (CDw26) induces human T lymphocyte activation. (1990) (51)
Cross‐linking of VLA/CD29 molecule has a co‐mitogenic effect with anti‐CD3 on CD4 cell activation in serum‐free culture system (1991) (50)
Enhancement of natural killer function through activation of the T11 E rosette receptor. (1987) (50)
Focal Adhesion Kinase (pp125FAK) Is Tyrosine Phosphorylated after Engagement of α4β1 and α5β1 Integrins on Human T-Lymphoblastic Cells (1995) (49)
Regulation of in vitro primary anti-DNP antibody production by functional subsets of T lymphocytes in man. (1981) (49)
Expression of Myeloid Differentiation Antigens in Acute Myeloblastic Leukemia (1984) (49)
The functional dissection of human peripheral null cells with respect to antibody‐dependent cellular cytotoxicity and natural killing (1979) (48)
Human leukemia-associated antigen: relation to a family of surface glycoproteins. (1980) (48)
Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia. (1981) (47)
CD11 molecule defines two types of suppressor cells within the T8+ population. (1988) (47)
Characterization of a unique cell line (LAZ 221) from human acute lymphocytic ("null" cell) leukemia. (1978) (47)
Surface molecules involved in self-recognition and T cell activation in the autologous mixed lymphocyte reaction. (1984) (46)
Immunologic heterogeneity of diffuse large cell lymphoma. (1985) (46)
Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro. (1976) (46)
The 1A4 molecule (CD27) is involved in T cell activation. (1991) (46)
Identification of the sequence required for expression of the 2H4 epitope on the human leukocyte common antigens (1987) (45)
Identification of a 140‐kDa activation antigen as a target structure for a series of human cloned natural killer cell lines (1984) (45)
Heterogeneity in the B1 (CD20) cell surface molecule expressed by human B-lymphocytes. (1988) (45)
Leukocyte inhibitory factor (LIF): production by purified human T and B lymphocytes. (1975) (45)
Phenotypic and functional distinctions between the TH2+ and JRA+ T cell subsets in man. (1979) (44)
Reactivity of inducer cell subsets and T8-cell activation during the human autologous mixed lymphocyte reaction. (1984) (44)
Function of the LFA‐1 and T4 molecules in the direct activation of resting human B lymphocytes by T lymphocytes (1986) (44)
T cell regulation of myelopoiesis: analysis at a clonal level. (1984) (44)
The specificity of antigen-induced thymidine-2-14C incorporation into lymph node cells frrom sensitized animals. (1968) (43)
ANTIGEN RECOGNITION: IN VITRO STUDIES ON THE SPECIFICITY OF THE CELLULAR IMMUNE RESPONSE (1969) (43)
The functional heterogeneity of CD8+ cells defined by anti-CD45RA (2H4) and anti-CD29 (4B4) antibodies. (1990) (43)
Branhamella catarrhalis activates human B lymphocytes following interactions with surface IgD and class I major histocompatibility complex antigens. (1988) (43)
T and B cell in hapten-specific carrier-determined tolerance (1975) (42)
Effect of activation of protein kinase C on CD45 isoform expression and CD45 protein tyrosine phosphatase activity in T cells (1990) (42)
The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors. (1992) (41)
Monoclonal antibodies derived from BALB/c mice immunized with apoptotic Jurkat T cells recognize known autoantigens. (2001) (41)
Protein-nucleic acid interaction. I. Nuclease-resistant polylysine-ribonculeic acid complexes. (1966) (41)
The pharmacokinetics and toxicity of murine monoclonal antibodies and of gelonin conjugates of these antibodies. (1987) (41)
Generation of Monoclonal Antibodies to a Human Natural Killer Clone (41)
Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicity. (1979) (40)
Conservation of myeloid surface antigens on primate granulocytes. (1983) (40)
Structural characterization of CD6: properties of two distinct epitopes involved in T cell activation. (1989) (40)
Biochemical and phenotypic characterization of human basophilic cells derived from dispersed fetal liver with murine T cell factors. (1986) (40)
Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets. (1997) (40)
Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clusters. (1999) (39)
CD2 is functionally linked to the ζ‐natural killer receptor complex (1991) (39)
Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage. (1981) (39)
Derivation of human T-cell leukemias. (1981) (39)
T-cell surface antigens in a patient with blast crisis of chronic myeloid leukemia. (1983) (39)
Immunochemical studies on delayed and arthus-type hypersensitivity reactions. I. The relationship between antigenic determinant size and antibody combining site size. (1967) (39)
Regulatory interactions between members of the immunoglobulin superfamily. (1988) (38)
Generation of CD8 (T8) cytotoxic cells has a preferential requirement for CD4+2H4- inducer cells. (1988) (38)
The role of functionally distinct helper T lymphocyte subpopulations in the inductionof human B cell differentiation (1990) (38)
Antilymphocyte antibodies against CD4+2H4+ cell populations in patients with systemic lupus erythematosus. (1989) (37)
Preparation and immunologic properties of stereospecific alpha-dinitrophenylnonalysines. (1968) (37)
Hairy cell leukemia: a tumor of pre-plasma cells (1985) (37)
Antigen Recognition: The Specificity of T Cells Involved in the Cellular Immune Response (1972) (36)
Isolation and characterization of CD6- T cells from peripheral blood. (1994) (36)
Isolation and functional analysis of human B cell populations. I. Characterization of the B1+B2+ and B1+B2- subsets. (1985) (36)
Growth inhibition of human T cells by antibodies recognizing the T cell antigen receptor complex. (1987) (36)
T-cell regulation of human peripheral blood B-cells responsiveness (1977) (36)
Regulation of T cell clone function via CD4 and CD8 molecules. Anti-CD4 can mediate two distinct inhibitory activities. (1988) (36)
Correlation of the epitopes defined by anti-CD26 mAbs and CD26 function. (1998) (35)
Requirement of Fas(CD95), CD45, and CD11a/CD18 in monocyte-dependent apoptosis of human T cells. (1996) (35)
T-cell migration into allografts (1975) (35)
Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system. (1986) (34)
Antibody-dependent cellular cytotoxicity by allosensitized human T cells (1978) (33)
Functional characterization of the CD45R (2H4) molecule on CD8 (T8) cells in the autologous mixed lymphocyte reaction system (1989) (33)
CD4CD45R cells are preferentially activated through the CD2 pathway (1988) (33)
Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains. (1983) (32)
The human T cell receptor: appearance in ontogeny and biochemical relationship of alpha and beta subunits on IL-2 dependent clones and T cell tumors. (1983) (32)
Role of the 2H4 molecule in the activation of suppressor inducer function (1988) (32)
The 2H4 molecule but not the T3-receptor complex is involved in suppressor inducer signals in the AMLR system. (1987) (31)
Defective surface expression of attractin on T cells in patients with common variable immunodeficiency (CVID) (2001) (31)
Antibody-dependent cellular cytotoxicity and natural-killer-like activity are mediated by subsets of activated T cells. (1981) (31)
Systemic Lupus Erythematosus: Delineation of Subpopulations by Clinical, Serologic, and T Cell Subset Analysis (1985) (31)
Adjuvant regulation of T cell function. (1976) (30)
Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations. (1983) (30)
Functional analysis of distinct human T-cell subsets bearing unique differentiation antigens. (1977) (30)
Identification and isolation of a T4+T8+ cell with high T3 expression in human thymus: a possible late intermediate in thymocyte differentiation. (1987) (30)
The T4 lymphocyte in AIDS. (1985) (29)
The T4 molecule differentially regulating the activation of subpopulations of T4+ cells. (1987) (29)
Human B Cell-Associated Antigens: Expression on Normal and Malignant B Lymphocytes (1984) (29)
Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients. (1988) (29)
Human T cells can be directed to lyse tumor targets through the alternative activation/T11-E rosette receptor pathway. (1988) (28)
Expression of the NKTa clonotype in a series of human natural killer clones with identical cytotoxic specificity (1986) (28)
Regulation of CD4 and CD8 surface expression on human thymocyte subpopulations by triggering through CD2 and the CD3-T cell receptor. (1989) (28)
ANTIGEN RECOGNITION AND ANTIBODY SPECIFICITY (1971) (26)
Functional abnormalities associated with T lymphocytes from patients with chronic lymphocytic leukemia. (1980) (26)
The role of the macrophage in in vitro primary anti-DNP antibody production in man. (1981) (26)
Human Myelomonocytic Differentiation Antigens Defined by Monoclonal Antibodies (1984) (26)
A triplet of nuclease proteins (NP42-50) is activated in human Jurkat cells undergoing apoptosis. (1995) (26)
The CD4/CD8:p56lck complex in T lymphocytes: a potential mechanism to regulate T-cell growth. (1989) (26)
WEEKLY HIGH-DOSAGE GLUCOCORTICOSTEROID TREATMENT OF LYMPHOCYTIC LEUKEMIAS AND LYMPHOMAS. (1964) (25)
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. Delivery of ribosome-inactivating proteins to spleen and lymph node T cells. (1986) (25)
P. Rambotti Lecture. Human naive and memory T cells revisited: new markers (CD31 and CD27) that help define CD4+ T cell subsets. (1993) (25)
Studies on the specificity of antibody to 2,4-Dini-trophenyl-poly-L-lysines. (1968) (24)
Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines. (1984) (24)
In vitro nucleoside specific immune response by lymphocytes from systemic lupus erythematosus. (1983) (24)
Delineation of lymphocyte subsets in lymph nodes of nonhuman primates. (1984) (24)
Acute undifferentiated leukemia: induction of partial differentiation by phorbol ester. (1985) (24)
The role of p23,30-bearing human macrophages in antigen-induced T lymphocyte responses. (1979) (24)
Detection of apoptotic cells from peripheral blood of HIV‐infected individuals using a novel monoclonal antibody (1997) (23)
Structure of CD26 (dipeptidyl peptidase IV) and function in human T cell activation. (1997) (23)
Markers of human T cell subsets identified by alloantisera. (1979) (23)
Activation of immature cortical thymocytes through the T11 sheep erythrocyte binding protein. (1987) (22)
Molecular analysis of the interaction of p56lck with the CD4 and CD8 antigens. (1991) (22)
Generation of antigen-specific suppressor cells in vitro in man. (1983) (22)
Human macrophage-lymphocyte interaction in proliferation to soluble antigen. I. Specific delection of lymphocyte proliferative activity on macrophage monolayers. (1980) (22)
Isolation of myeloid progenitor cells from peripheral blood of chronic myelogenous leukemia patients. (1982) (22)
Discrete stages of human thymocyte activation and maturation in vitro: correlation between phenotype and function (1986) (21)
Human-human hybrids secreting pneumococcal antibodies. (1984) (21)
GENETIC CONTROL OF IMMUNE RESPONSES IN VITRO (1974) (21)
Expression of CD1 and class I MHC antigens by human thymocytes. (1989) (21)
Multimarker analysis of T-cell chronic lymphocytic leukemia. (1978) (20)
Primary in vitro anti-KLH antibody formation by peripheral blood lymphocytes in man: detection with a radioimmunoassay. (1981) (20)
Immunologic functions of isolated human lymphocyte subpopulations. IV. Stimulation of MLC and CML by human T cells. (1975) (20)
An experimental model of pulmonary arterial granulomatous inflammation. (1973) (20)
APO2.7 defines a shared apoptotic-necrotic pathway in a breast tumor hypoxia model. (1998) (20)
Isolation and characterization of human B lymphocyte enriched populations. I. Purification of B cells by immune rosette depletion. (1983) (19)
Inhibition of proliferative and plaque-forming cell responses by human bone-marrow-derived lymphocytes from peripheral blood by antisera to the p23, 30 antigen. (1977) (19)
Antigen recognition: the specificity of an isolated T lymphocyte population. (1977) (19)
Local transfer of delayed hypersensitivity and cutaneous basophil hypersensitivity. (1977) (19)
Class II major histocompatibility complex molecules regulate the development of the T4+T8- inducer phenotype of cultured human thymocytes. (1985) (19)
Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation. (1995) (19)
Dynamic parameters of membrane lipids in normal and leukemic human lymphocytes isolated from peripheral blood and bone marrow. (1978) (18)
Immunologic detection of intracellular and cell-surface lysozyme with human and experimental leukemic leukocytes. (1977) (18)
Utilization of Monoclonal Antibodies in the Characterization of Monocyte-Macrophage Differentiation Antigens (1984) (18)
Surface antigen changes during B-lymphocyte activation in primates. (1984) (18)
The B Cell-Restricted Glycoprotein (B2) Is the Receptor for Epstein-Barr Virus (1986) (18)
Common Tree Shrews and Primates Share Leukocyte Membrane Antigens (1984) (18)
Desensitization to delayed hypersensitivity reactions. With special reference to the requirement for an immunogenic molecule. (1967) (17)
Decreased ability of HIV-1 tat protein-treated accessory cells to organize cellular clusters is associated with partial activation of T cells. (1997) (17)
Antilymphocyte antibodies and systemic lupus erythematosus. (1987) (16)
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. IV. Cytotoxic effect of an anti-T11-gelonin immunotoxin. (1988) (16)
Activation of T cells through a T cell-specific epitope of CD45. (1992) (16)
Dual fluorochrome analysis of human B lymphocytes: phenotypic examination of resting, anti-immunoglobulin stimulated, and in vivo activated B cells. (1986) (16)
Development of natural killer cells in human thymocyte culture: regulation by accessory cells (1987) (16)
IMMUNOCHEMICAL STUDIES ON THE SPECIFICITY OF CELLULAR AND ANTIBODY‐MEDIATED IMMUNE REACTIONS * (1970) (16)
Identification of amino acids at the junction of exons 3 and 7 that are used for the generation of glycosylation-related human CD45RO and CD45RO-like antigen specificities (1994) (16)
Differential regulation of Ca2+ mobilization in human thymocytes by coaggregation of surface molecules. (1990) (15)
The effects of antigen dose and adjuvant on the antibody response; amplification of restricted B cell clones. (1976) (15)
Development of an antigen-specific CD8 suppressor effector clone in man. (1988) (15)
Natural killer-like activity mediated by activated T lymphocytes. (1984) (15)
T and B lymphocyte migration into syngeneic tumors. (1977) (15)
Cell‐surface characteristics of hairy cell leukemia in seven patients (1979) (15)
CD27/CD70 interaction contributes to the activation and the function of human autoreactive CD27+ regulatory T cells. (1997) (15)
Human CD4/CD45RA+ and CD4/CD45RA- T cell subsets express CD4-p56lck complexes, CD4-associated lipid kinases, TCR/CD3-p59fyn complexes, and share similar tyrosine kinase substrates. (1993) (14)
Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantation. (1994) (14)
Fc, receptor type III (CD16) is included in the ; NK receptor complex expressed by human natural killer cells (14)
Depletion of the helper/inducer (memory) T cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD29. (1993) (14)
Expression and tyrosine phosphorylation of the T cell receptor zeta-subunit in human thymocytes. (1991) (14)
Anti-T cell antibody in juvenile rheumatoid arthritis. (1984) (13)
Human cell lines express multiple populations of Ia-like molecules. (1981) (13)
Induction and detection of apoptosis in human periphery blood T-cells. (1997) (13)
Human T lymphocyte surface antigens: partial purification and characterization utilizing a high-titer heteroantiserum. (1980) (13)
Generation and specificity of a heteroantiserum to human peripheral blood monocytes. (1980) (13)
Studies on the specificity and affinity of alpha, DNP-oligolysine antibody: a basis for questioning the role of cell-bound antibody in cellular recognition of antigen. (1970) (13)
The immune response. Some unifying concepts. (1967) (13)
CD2 is functionally linked to the zeta-natural killer receptor complex. (1991) (12)
Mo2: functional properties of antigen-bearing cells. (1983) (12)
The Chediak-Higashi gene in humans. III. Studies on the mechanisms of NK impairment. (1983) (12)
Focal adhesion kinase (pp125FAK) is tyrosine phosphorylated after engagement of alpha 4 beta 1 and alpha 5 beta 1 integrins on human T-lymphoblastic cells. (1995) (12)
Human thymocyte maturation in vitro: a flow cytometric analysis. (1986) (12)
Effect of phorbol ester on differentiation of human myeloid colony forming cells (CFU-C). (1983) (12)
Selective inhibition of anti-nucleoside-specific antibody production by nucleoside-ricin A conjugate. (1983) (11)
Development of a monoclonal antibody, anti-6C2, which is involved in the interaction of CD4 T helper cells and activated B cells. (1991) (11)
The characterization and function of human immunoregulatory T lymphocyte subsets. (1982) (11)
Characterization of human thymic epithelial cells grown in serum-free medium. (1984) (11)
Different Regulatory Effects of Pentoxifylline on Human T Cell Activation Pathways (1997) (11)
Monoclonal anti-T12 antibody as therapy for renal allograft rejection. (1983) (10)
Human T-cell subsets in health and disease (2005) (10)
Local transfer of delayed hypersensitivity by T lymphocytes. (1973) (10)
Synthesis and immunological properties of the oligolysyl-N-epsilon-dinitrophenyllysine and oligolysylalanylalanylalanyl-N-epsilon-dinitrophenyllysine peptide series. (1974) (10)
Direct demonstration of the CD27 molecule involved in the negative regulatory effect on T cell activation. (1993) (10)
Immune response gene control of antibody specificity. (1982) (10)
Studies of the in vitro activation and differentiation of human B lymphocytes. II. Optimization of activation by anti-immunoglobulin antibody bound to beads: analysis of the role of autocrine effects on B-cell proliferation and of T-cell help in B-cell differentiation. (1986) (10)
Requirements for the construction of antibody heterodimers for the direction of lysis of tumors by human T cells. (1988) (10)
Human macrophage--lymphocyte interaction in proliferation to soluble antigen. II. Characterization of lymphocyte binding to antigen-pulsed macrophage monolayers. (1980) (9)
Leucocyte typing V : white cell differentiation antigens : proceedings of the Fifth International Workshop and Conference held in Boston, USA, 3-7 November, 1993 (1995) (9)
Cellular interaction between subsets of T8 population for maximal suppression of antigen-specific antibody response. (1984) (9)
Characterization of Regulatory T Cells in Man (1980) (9)
Studies on the cellular basis for partial tolerance: antigen-specific suppression of antigen-induced thymidine-2-14C incorporation in vitro. (1971) (9)
The detection of Ia-like and DRw antigens on activated T cells. (1979) (9)
A rapid method for the isolation of human peripheral null lymphocytes. (1979) (9)
T‐cell subsets in human autoimmune diseases (1982) (9)
Novel approach to construction of human "myeloma analogues" for production of human monoclonal antibodies. (1983) (9)
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. V. Evidence that humoral immune response to monoclonal antibodies and immunotoxin conjugates abrogates their cytotoxic activity. (1989) (9)
Phenotypic abnormalities in CD8+ T lymphocyte subsets in patients with rheumatoid arthritis. (1991) (9)
CD45 isoforms associated with distinct functions of CD4 cells derived from unusual healthy donors lacking CD45RA- T lymphocytes. (1991) (8)
Targeting of an Activated T-cell Subset Using a Bispecific Antibody-Toxin Conjugate Directed Against CD4 and CD26 (1993) (8)
Internalization of CD 26 by mannose 6-phosphate y insulin-like growth factor II receptor contributes to T cell activation (2000) (8)
Specificity of heteroantisera developed against purified populations of intact murine ovarian carcinoma cells. (1980) (8)
Functional characteristics of human T-lymphocyte subsets identified by sera from patients with systemic lupus erythematosus. (1979) (8)
Changes with in vitro Activation of the B Cell Panel Antigens (1986) (8)
Monoclonal antibody 4B4 blocks suppression of the immune response to Cryptomeria japonica pollen antigen. (1988) (7)
Anti-T12 monoclonal antibody therapy of acute renal allograft rejection. (1987) (7)
T cell and IR gene regulation of expression of a cross-reactive idiotype. (1982) (7)
Crosslinking CD3 with CD2 using sepharose-immobilized antibodies enhances T lymphocyte proliferation. (1988) (7)
CD 27-CD 70 interactions regulate B-cell activation by T cells ( tumor necrosis factor receptor family / immunoregulation ) (2005) (7)
IMMUNOCHEMICAL STUDIES ON PULLULAN, AN EXTRACELLULAR POLYSACCHARIDE FROM PULLULARIA PULLULANS. (1963) (7)
Biochemical characterization of Ia alloantigens in guinea pigs. I. Synthesis of Ia antigens by subsets enriched for B cells, T cells, or macrophages. (1981) (6)
New approaches to the treatment of non-Hodgkin's lymphoma. (1977) (6)
Characterization of the CD8+CD45R+(2H4+) suppressor effector cell. (1989) (6)
The T cell circuit: clinical and biological implications. (1986) (6)
Pillars article: the CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. 1988. (2010) (6)
Definition of the T-lymphocyte inducer of suppression in primates using a monoclonal antibody. (1985) (6)
Experimental intradermal granuloma formation. (1974) (6)
Antigenic markers on human monocytes and macrophages. (1982) (6)
Pillars Article: The CD4 Receptor Is Complexed in Detergent Lysates to a Protein-Tyrosine Kinase (Pp58) from Human T Lymphocytes. Proc. Natl. Acad. Sci. USA 1988. 85: 5190–5194 (2010) (6)
Lectin Activation Induces T4, T8 Coexpression on Peripheral Blood T Cells (1986) (6)
Amplification of suppressor inducer pathway with monoclonal antibody, anti-2H4, identifying a novel epitope of the common leukocyte antigen/T200 antigen. (1989) (5)
In vitro lymphocyte responses. (1970) (5)
Immunohistochemical analysis of suppressor-inducer and helper-inducer T cells in multiple sclerosis brain tissue (1987) (5)
Characterization and function of human lymphocyte subsets. (1981) (5)
Use of radiolabeled monoclonal anti-B1 antibody for B lymphocyte imaging in rhesus monkeys. (1987) (5)
Serologic analysis of MLC determinants. (1977) (5)
Phenotypic Changes Occurring during in vitro Activation of Human Splenic B Lymphocytes (1986) (5)
Potentiation of cytotoxic T-cell function by virus. (1976) (4)
The specificity of the secondary immune response: characterization of the antibody produced to cross-reactive antigens. (1970) (4)
Characterization of the T3+T4+T8+ thymocyte intermediate in vitro. (1987) (4)
The Development of Monoclonal Antibodies against Human Immunoregulatory T Cell Subsets: The Isolation of Human Suppressor Inducer T Cell Subset (1986) (4)
Identification and characterization of human T lymphocyte antigens. (1984) (4)
The secondary immune response: the specificity of lymph node cells and antibody. (1972) (3)
Specificity and genetic restrictions of the guinea-pig immune response to dinitrophenyl-lysyl-alanyl octapeptides. (1978) (3)
Absence of expression of IA antigen on human cytotoxic T cells (2005) (3)
Use of anti-Fab columns for the isolation of human lymphocyte populations. (1984) (3)
Transplantation with anti-B1 monoclonal antibody and complement treated autologous bone marrow for relapsed B-cell non-Hodgkin’s lymphoma (1985) (3)
Differential regulation of CD27 expression on subsets of CD4 T cells. (1994) (3)
Studies on the production of MIF and mitogenic factor using highly purified human T and B lymphocytes. (1975) (3)
Chapter 1 – Use of Monoclonal Antibodies in the Study of Autoimmunity and Immunodeficiency1 (1983) (3)
ISOLATION AND STRUCTURE OF PRODUCTS OF THE HUMAN HISTOCOMPATIBILITY GENE COMPLEX (1976) (3)
Targeting of an activated T-cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD26. (1993) (3)
Pillars article: Monoclonal antibodies defining distinctive human T cell surface antigens. Science. 1979. 206: 347-349. (2013) (2)
Human B Cell Populations Defined by the B1 and B2 Antigens (1986) (2)
Alterations ofT-cell subsets inprimary biliary cirrhosis (1982) (2)
Pillars article: Separation of functional subsets of human T cells by a monoclonal antibody. Proc. Natl. Acad. Sci. 1979. 76: 4061-4065. (2013) (2)
NK-Associated and LFA-1 Antigens: Phenotypic and Functional Studies Utilizing Human NK Clones (1986) (2)
Clonal analysis of human cytotoxic T lymphocytes : T 4 ' and T 8 ' effector T cells recognize products of different major histocompatibility complex regions ( major histocompatibility complex gene products / cytotoxicity / monoclonal antibodies ) (2)
Molecular analysis of the human T-cell-antigen receptor. (1985) (2)
The human immunoregulatory T cell circuit: recent progress and its clinical implications. (1987) (2)
Human T and B cell derived malignancies. (1983) (2)
Immunologic Functions of Isolated Human Lymphocyte Subpopulations (1974) (2)
3H11, a unique cell surface molecule involved in the function of the CD45RA+ subset of CD4+ cells. (1994) (2)
The human T-cell circuit--biologic and clinical implications. (1983) (1)
Expression of Normal Differentiation Antigens on Human Leukemias and Lymphomas (1983) (1)
Monoclonal antibodies as probes to define human t cell surface structures and functions (1985) (1)
DIFFERENTIAL ACTIVATION AND SPECIFICITY OF INDIVIDUAL HUMAN T CELL SUBPOPULATIONS (1982) (1)
Dissection of the T-cell circuit with monoclonal antibodies (1984) (1)
In Memoriam Elvin Abraham Kabat September 1, 1914–June 16, 2000 (2001) (1)
Immune ascites in the guinea pig: specificity of cells and antibody in an induced peritoneal exudate. (1977) (1)
MEDIATOR PRODUCTION BY HUMAN T AND B LYMPHOCYTES (2003) (1)
223 Regulation of IgE synthesis (1983) (1)
Defective Expression of the 2 H 4 Molecule after Autologous Mixed Lymphocyte Reaction Activation in Systemic Lupus Erythematosus Patients (2013) (1)
EVIDENCE FOR THE T3-ASSOCIATED 90-KD (49/43) HETERODIMER AS THE T-CELL ANTIGEN RECEPTOR (1983) (1)
Serotherapy and Bone Marrow Transplantation (1985) (1)
Activation of natural killer function through the T11/E rosette receptor. (1987) (1)
Partial Structural Characterization of Human SB Antigens (1983) (1)
Interactions Between Two Antigens Governed by the Poly-L-lysine Gene: Failure of One to Inhibit Competitively an in Vitro Response to the Other 1 (1974) (1)
Direct demonstration of the function of T cell subsets reactive with anti-T cell antibodies from SLE sera (1982) (1)
T-cell regulation of restricted B-cell responses. (1978) (1)
Attractin (Mahogany, DPPT-L) (2002) (0)
Patents and literature (1985) (0)
InVivoAdministration ofLymphocyte-specific Monoclonal Antibodies inNonhumanPrimates (1986) (0)
Surface Antigens in a Patient With Blast Crisis of Chronic Myeloid Leukemia (2005) (0)
Investigation of Cell-Mediated Lympholysis (2003) (0)
Dr. Elvin Kabat: an appreciation of his scientific contributions. (1984) (0)
The essential role of the thymus in the differentiation and functional maturation of bone marrow-derived precursors into immunocompetent T lymphocytes is well estab- (2003) (0)
Growth of human thymic epithelium in serum free medium (1982) (0)
Editorial: BCG and lymphoma. (1974) (0)
Mono clonal antibody to acute leukocytic leukemia associated antigens (1980) (0)
Identification and functional characterization of a TIA-1-related nucleolysin ( apoptosis / p d cell death / cytolytic lymphocytes / cytotoxic granules ) (0)
Discrete stages ofhumanintrathymic differentiation: Analysis of normalthymocytes andleukemic lymphoblasts ofT-cell lineage (1980) (0)
Biology of the T cell. (1986) (0)
DISSECTION OF HUMAN IMMUNOREGULATORY T LYMPHOCYTES: IMPLICATIONS FOR UNDERSTANDING CLINICAL DISEASE (1983) (0)
[Control of the specificity of B-lymphocytes (proceedings)]. (1978) (0)
Methods for the separation and purification of populations and subpopulations of lymphoreticular cells (1984) (0)
A monoclonal antibody which distinguishes between helper lymphocyte-inducer and suppressor-inducer CD4 + (1990) (0)
The human T-cell circuit. (1984) (0)
Inhibition of proliferative and plaque-forming cell responses by human bone-marrow-derived lymphocytes from peripheral blood by antisera to the p 23 , 30 antigen ( Ia antigen ) (0)
in the Treatment of Leukemia and Lymphoma (2016) (0)
Clonal Analysis of Human Immunoregulatory and Effector T Lymphocytes in Viral Infection (1984) (0)
T Cell Ontogeny: Acquisition of a Functional Program (1986) (0)
cell pool nonhuman primates: I. Effects of anti-T11 antibodies on the circulating T In vivo administration of lymphocyte-specific monoclonal antibodies in (2011) (0)
BCG and Lymphoma (1974) (0)
The T lymphoblastic malignancies (2004) (0)
Acute Lymphocytic ( ' ' Null ' ' Cell ) Leukemia Characterization of a Unique Cell Line ( LAZ 221 ) from Human Updated (2006) (0)
cells from normal human bone marrow Purification of common acute lymphoblastic leukemia antigen positive (2011) (0)
Desensitization to Delayed Hypersensitivity Reactions (1967) (0)
Rapid Publication Enhancement of Natural Killer Function Through Activation of the TI 1 E Rosette Receptor (2013) (0)
Brief Definitive Report Interleukin 2-induced Proliferation of Leukemic Human B Cells (2003) (0)
Bifunctional antibody structure and selective breakage of cell population (1988) (0)
98 (2) Physical Structure of a Native Protoplasmic Polysaccharide from Escherichia Coli. Studies on Human Peripheral Blood Lymphocytes in Vitro: Iii. Fine Structural Features of Lym- Phocyte Transformation Immunologic Relationship between Blood Group Substances and a Fucose-containing Glyco- Lipid o (2006) (0)
The Association of p56 lck with the CD4/CD8 Antigens: Implications for T-Cell Function (1989) (0)
United States Patent is Schlossman (2017) (0)
Human thymocyte subpopulations: maturational stages defined by the expression of the T3-T cell receptor complex. (1987) (0)
Cd4 positive cd45r positive and cd45r negative subsets in man remain distinct after activation with con a (1989) (0)
Use of Monoclonal Antibodies as Diagnostic and Therapeutic Reagents in Acute Lymphoblastic Leukemia 1 (2006) (0)
lymphomas of B-cell and T-cell lineage Expression of common acute lymphoblastic leukemia antigen (CALLA) by (2011) (0)
Adjuvant induced suppressor cells. Abstr. (1976) (0)
lymphoblastic leukemia Cell surface antigens: prognostic implications in childhood acute (2011) (0)
Lymphocyte Activation: Modulatory Effects Mediated by Interactions between Cell Adhesion Molecules (1988) (0)
Clonogenic assays: production and use of monoclonal antibodies to obtain a selective assay system. Abstr. (1982) (0)
T-Cell Subsets: Role of Cell Surface Structures. (1992) (0)
Derivation of Human T-Cell Leukemias1 (2006) (0)
Bifunctional antibody constructions and methods for the selective killing of cell stocks. (1988) (0)
A monoclonal antibody specific to the functional adhesion area of the surface protein of a phagocyte cell. (1988) (0)
Construction bifonctionnelle d'anticorps et procédé de destruction sélective de populations de cellules (1988) (0)
Protein kinase A-mediated phosphorylation of the T-cell surface antigen CD27. (1993) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stuart F. Schlossman?

Stuart F. Schlossman is affiliated with the following schools:

Stuart F. Schlossman's Academic­Influence.com Rankings

Why Is Stuart F. Schlossman Influential?

Stuart F. Schlossman's Published Works

Published Works

What Schools Are Affiliated With Stuart F. Schlossman?

Stuart F. Schlossman's AcademicInfluence.com Rankings